Mayukh Sukhatme
CIK 1750050 · President & CIO · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$758.18M
Companies
2
Total Filings
30
Lifetime Open-Market Net
-$88.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | President & CIO | 20,288,437 | $37.37 | $758.18M | -$88.23M | 13 | 2026-07-02 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Pres&Chief Investment Officer | 4,847,658 | $2.75 | $13.33M | $0 | 4 | 2023-08-29 |
Recent Filings · Page 3 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-18 | ROIV | Notice (144) | −412,584 | -$4.97M | EDGAR |
| 2024-12-05 | ROIV | Other (J) | −3,651,985 | -$44.57M | EDGAR |
| 2024-07-30 | ROIV | Grant (A) | +18,836,547 | $0 | EDGAR |
| 2024-04-02 | ROIV | Mixed | +362,870 | -$3.86M | EDGAR |
| 2023-12-29 | ROIV | Exer (M) | +71,365 | $0 | EDGAR |
| 2023-09-29 | ROIV | Exer (M) | +27,790 | $0 | EDGAR |
| 2023-08-29 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +22,565 | $0 | EDGAR |
| 2023-07-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +43,212 | $0 | EDGAR |
| 2023-05-31 | Roivant Sciences Ltd. (ROIVW) Delisted | Exer (M) | +99,458 | $0 | EDGAR |
| 2022-04-22 | Roivant Sciences Ltd. (ROIVW) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.